Acute and subacute effects of nicorandil and isosorbide dinitrate on vessel wall properties of large arteries and hemodynamics in healthy volunteers
- PMID: 7662600
- DOI: 10.1007/BF00878678
Acute and subacute effects of nicorandil and isosorbide dinitrate on vessel wall properties of large arteries and hemodynamics in healthy volunteers
Abstract
Nicorandil (N) and isosorbide dinitrate (ISDN) are vasodilator drugs used in patients with angina. In 24 healthy male volunteers (18-32 years), the acute effect of a single oral dose (20 mg) of N and ISDN on arterial diameter (D), distensibility, and compliance of the elastic common carotid artery (CCA) and the muscular femoral (FA) and brachial (BA) arteries were investigated. The effects on systolic and diastolic blood pressure (SBP, DBP), heart rate (HR), cardiac index (CI), systemic vascular resistance index (SVRI), and venous hemodynamics were also assessed. In addition, the subacute effects after 8 days of treatment with N (2 x 20 mg/day) and ISDN (3 x 20 mg/day) on these parameters were evaluated. After a 20 mg single oral dose, blood pressure decreased significantly more with ISDN (SBP: 6%; DBP: 14%) than with N (SBP: 2%; DBP: 6%), but after 8 days this decrease in blood pressure was not statistically different between ISDN and N. The diameter of CCA increased more with ISDN (11%) than N (5%) acutely as well as subacutely (ISDN: 12%; N: 9%). Heart rate increased only with ISDN (7% acutely, 3% subacutely). No differences between ISDN and nicorandil were found for acute and subacute effects on SVRI, venous hemodynamics, diameter of muscular arteries (FA, BA), and the distensibility and compliance of elastic (CCA) and muscular (FA, BA) arteries.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Mechanism of nitrate-induced improvement on arterial compliance depends on vascular territory.J Cardiovasc Pharmacol. 1992 Apr;19(4):641-9. doi: 10.1097/00005344-199204000-00023. J Cardiovasc Pharmacol. 1992. PMID: 1380609 Clinical Trial.
-
Hemodynamic effects of nicorandil, isosorbide dinitrate, and dihydralazine in healthy volunteers.J Cardiovasc Pharmacol. 1985 Nov-Dec;7(6):1107-12. doi: 10.1097/00005344-198511000-00015. J Cardiovasc Pharmacol. 1985. PMID: 2418296 Clinical Trial.
-
Cardiovascular effects of isosorbide dinitrate infused intravenously into anaesthetized dogs.Clin Exp Pharmacol Physiol. 1986 Aug;13(8):619-28. doi: 10.1111/j.1440-1681.1986.tb00947.x. Clin Exp Pharmacol Physiol. 1986. PMID: 2947766
-
Haemodynamic and clinical effects of an intravenous potassium channel opener--a review.Eur Heart J. 1993 Jul;14 Suppl B:40-7. doi: 10.1093/eurheartj/14.suppl_b.40. Eur Heart J. 1993. PMID: 8370372 Review.
-
Comparison of the antianginal efficacy of isosorbide dinitrate (ISDN) 40 mg and verapamil 120 mg three times daily in the acute trial and following two-week treatment.Eur Heart J. 1988 Feb;9(2):149-58. doi: 10.1093/oxfordjournals.eurheartj.a062468. Eur Heart J. 1988. PMID: 3280317 Review.
Cited by
-
Prognostic Impact of Chronic Vasodilator Therapy in Patients With Vasospastic Angina.J Am Heart Assoc. 2022 Apr 5;11(7):e023776. doi: 10.1161/JAHA.121.023776. Epub 2022 Mar 29. J Am Heart Assoc. 2022. PMID: 35347998 Free PMC article.
-
[Nicorandil: acute hemodynamic effects of 2 different oral doses of a potassium channel opener in patients with coronary heart disease].Med Klin (Munich). 1999 Feb 15;94(2):67-73. doi: 10.1007/BF03044702. Med Klin (Munich). 1999. PMID: 10194949 Clinical Trial. German.
-
Nicorandil and Long-acting Nitrates: Vasodilator Therapies for the Management of Chronic Stable Angina Pectoris.Eur Cardiol. 2018 Aug;13(1):23-28. doi: 10.15420/ecr.2018.9.2. Eur Cardiol. 2018. PMID: 30310466 Free PMC article. Review.
-
The Role of Nicorandil in the Management of Chronic Coronary Syndromes in the Gulf Region.Adv Ther. 2021 Feb;38(2):925-948. doi: 10.1007/s12325-020-01582-w. Epub 2020 Dec 22. Adv Ther. 2021. PMID: 33351175 Free PMC article. Review.
-
Vasodilator Therapy: Nitrates and Nicorandil.Cardiovasc Drugs Ther. 2016 Aug;30(4):367-378. doi: 10.1007/s10557-016-6668-z. Cardiovasc Drugs Ther. 2016. PMID: 27311574 Free PMC article. Review.